Search Within

Jonathan Eric Rosenberg

Formats
  1. Meeting Abstract (283)
  2. Journal Article (195)
  3. Review (18)
  4. Correspondence (10)
  5. Editorial (5)
  6. Guidelines (4)
  7. Book Section (2)
  8. Research Letter (2)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (520)
  2. Genitourinary Oncology Service (520)
  3. Solid Tumor Oncology Division (520)
  4. Department of Pathology and Laboratory Medicine (149)
  5. Surgery (140)
  6. Urology (137)

More Groups

People
  1. Dean Bajorin (204)
  2. Gopakumar Iyer (175)
  3. Hikmat Al-Ahmadie (134)
  4. Bernard Bochner (124)
  5. David Solit (114)
  6. Min Yuen Teo (75)

More People

Years
  1. 2025 (23)
  2. 2024 (36)
  3. 2023 (32)
  4. 2022 (36)
  5. 2021 (48)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (204)
  2. Annals of Oncology (42)
  3. European Urology (20)
  4. Clinical Genitourinary Cancer (18)
  5. Clinical Cancer Research (16)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (210)
  2. Oxford University Press (47)
  3. Elsevier Inc. (39)
  4. Elsevier Science, Inc. (36)
  5. Nature Publishing Group (36)
  6. American Association for Cancer Research (35)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Meeting Abstract

    Rosenberg, J. E.; Van Allen, E. M.; Mouw, K. W.; Kim, P. H.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Galsky, M. D.; Harshman, L. C.; Crabb, S. J.; Wong, Y. N.; Yu, E. Y.; Chowdhury, S.; Powles, T.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer
    Meeting Abstract

    Choueiri, T. K.; Hahn, N. M.; Pai, S. K.; Alva, A. S.; Drelcer, R.; Starodub, A.; Sonpavde, G.; Hoffman-Censlts, J. H.; Plcus, J.; Baler, A. V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors
    Meeting Abstract

    Bellmunt, J.; Werner, L.; Leow, J. J.; Mullane, S. A.; Riester, M.; Van Hummelen, P.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Comprehensive characterization of urothelial bladder cancer: A TCGA Project update
    Meeting Abstract

    Weinstein, J. N.; Kim, J.; Creighton, C. J.; Akbani, R.; Hoadley, K. A.; Kim, W. Y.; Morgan, M. B.; Hinoue, T.; Cherniack, A.; Su, X.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • ARHGAP30 and DEDD as potential genomic drivers of invasive urothelial carcinomas
    Meeting Abstract

    Hong, A. L.; Riester, M.; Schinzel, A. C.; Schlauch, A.; Adam, R. M.; Kwiatkowski, D. J.; Rosenberg, J. E.; Hahn, W. C.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Frequency and function of ERBB3 mutations in bladder cancer
    Meeting Abstract

    Hanrahan, A. J.; Sfakianos, J. P.; Ramirez, R.; Kim, P. H.; Iyer, G.; Al-Ahmadie, H. A.; Scott, S. N.; Bajorin, D. F.; Bochner, B. H.; Coleman, J. A.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The landscape of actionable genomic lesions in small cell bladder cancer
    Meeting Abstract

    Chang, M. T.; Asthana, S.; Iyer, G.; Desai, N.; Al-Ahmadie, H.; Chapman, J.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D. F.; Solit, D. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
    Journal Article

    Milowsky, M. I.; Dittrich, C.; Durán, I.; Jagdev, S.; Millard, F. E.; Sweeney, C. J.; Bajorin, D.; Cerbone, L.; Quinn, D. I.; Stadler, W. M.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
    Journal Article

    Guancial, E. A.; Werner, L.; Bellmunt, J.; Bamias, A.; Choueiri, T. K.; Ross, R.; Schutz, F. A.; Park, R. S.; O'Brien, R. J.; Hirsch, M. S.; more...
    Cancer Medicine (2014)

    Fulltext@MSK | Save